UltraTech stock gains as HSBC backs premium valuation and shares jump over 4 percent

Published on 09/21/2026 at 13:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UltraTech stock trades around INR 11,060 on September 21, 2026 after HSBC reiterates its Buy rating with a INR 14,200 target price. The cement major’s recent share move places it among the day’s top Sensex gainers with a market cap above INR 3.1 trillion.

UltraTech, INE469A01017, Illustration mit AI erstellt.

UltraTech Cement Ltd. stock (ISIN INE469A01017) traded around INR 11,060 on the National Stock Exchange of India as of September 21, 2026, putting India’s largest cement producer among the top gainers on the Sensex with an intraday rise of more than 4 percent at one point.

HSBC sees UltraTech valuation premium as sustainable

According to INDIA IPO on September 21, 2026, HSBC reiterated its Buy rating on UltraTech Cement and maintained a target price of INR 14,200 per share, arguing that the company’s premium valuation relative to domestic peers is supported by its scale, leadership position and balance-sheet strength.

As INDIA IPO reported on September 21, 2026, UltraTech Cement shares were trading about 0.4 percent higher at around INR 11,060 on the NSE, while on the BSE the shares were quoted near INR 11,059.90, reflecting investor support for the stock after the HSBC note.

Stock among the strongest Sensex gainers

In the broader market context, UltraTech Cement featured prominently among the day’s top gainers on the benchmark indices. As Moneycontrol reported on September 21, 2026, UltraTech Cement surged 4.08 percent to INR 11,105 during the session, briefly leading the Sensex gainers list as investors rotated into large-cap cyclicals.

A similar picture emerged on the BSE index, where UltraTech Cement was also highlighted as a major gainer. According to Amrapali on September 21, 2026, UltraTech Cement traded at INR 11,120, up 4.22 percent, putting it ahead of other notable risers such as HCL Technologies and Sun Pharmaceutical Industries on the Sensex.

Analyst support from Jefferies alongside HSBC

Investors also took note of positive commentary from other research houses. As Zee Business reported on September 21, 2026, both HSBC and Jefferies retained their Buy calls on UltraTech Cement, with the stock trading at INR 11,015 on the BSE, up 3.23 percent intraday, underscoring sustained analyst confidence in the company’s earnings trajectory and capacity expansion plans.

While the detailed price-target framework of Jefferies was not fully disclosed in the recent coverage, the combination of HSBC’s INR 14,200 target price and Jefferies’ supportive stance indicates that key global houses see further upside from the current price zone around INR 11,000, implying a potential upside of roughly 28 percent from the HSBC target alone if realized over the medium term.

Valuation and market capitalization context

UltraTech Cement’s rally on September 21, 2026 takes place against the backdrop of already substantial equity value. A peer-comparison overview cited by Univest on September 21, 2026 lists UltraTech Cement with a market capitalization of INR 3,14,422.68 crore, a price-earnings ratio of 36.82 and a price-to-book ratio of 3.98, alongside return on equity of 11.14 percent and return on capital employed of 13.25 percent.

The same metrics underline why HSBC characterizes UltraTech’s valuation as a premium compared with other Indian cement producers: at a P/E of 36.82, investors are currently willing to pay more than 36 times trailing earnings for UltraTech, compared with lower multiples for several peers, reflecting expectations of higher growth, strong cash generation and strategic importance in India’s infrastructure build-out.

Risks and sector backdrop

The current strength in UltraTech stock is supported by broader Indian equity market sentiment. As The Week noted on September 21, 2026, the Sensex gained more than 490 points as lower crude oil prices and renewed foreign institutional investor inflows improved risk appetite, helping cyclicals such as UltraTech Cement, Asian Paints and Sun Pharma.

At the same time, analyst commentary such as that from HSBC stresses that maintaining UltraTech’s valuation premium will depend on sustained demand growth, disciplined capacity additions and margin management in the face of input-cost volatility and competitive pressures across the cement industry.

UltraTech stock price level and trading data

On the primary listing at the National Stock Exchange of India, recent quotes around midday on September 21, 2026 showed UltraTech Cement trading near INR 11,100, with various intraday data snapshots indicating moves between approximately 0.78 percent and 4.22 percent higher than the prior close, depending on the specific time of observation during the session as reported by market overviews such as those on Scanx Trade and Amrapali.

Given the market capitalization of about INR 3,14,422.68 crore as highlighted by the sector metrics overview on September 21, 2026, UltraTech’s share-level moves translate into sizeable shifts in equity value, and for investors the current price zone around INR 11,000 also needs to be considered in light of the INR 14,200 target price reiterated by HSBC and supportive views from Jefferies.